Company initiatives
-
Sophorolipids from Mahua Oil
.
Aside from Tecnon OrbiChem’s coverage of oleochemicals on the monthly Bio-Materials newsletter, I have not covered much of the bio-based surfactants market in months. However, the blog recently received an interesting information on sophorolipids, a fermentation-based glycolipids that can be…
-
Versalis, Elevance Partnership
.
Given my limited background in organic chemistry, I am still trying to comprehend the potential importance of olefin metathesis technology within the overall chemical industry. However, Elevance has a nice summary of what metathesis is all about on its web…
-
Amyris expands squalene sales in Korea
.
Amyris has selected Dowell C&I Co., Ltd., a supplier of ingredients for the personal care industry, as its exclusive distributor of Neossance™ Squalane in the Republic of Korea. The company is planning to double its sugar-based squalene sales in 2014….
-
ADM invests in Rennovia
.
I just had an interesting conversation with Elevance regarding their partnership with Versalis, and I will try to post a blog soon. In the meantime, I just received this news from Archer Daniels Midland about its $25 million equity investment…
-
Scotland launches new industrial biotechnology center
.
Funded by the Scottish Funding Council and supported by Scottish Enterprise and Highlands & Islands Enterprise, the new Industrial Biotechnology Innovation Centre (IBioIC) has been launched, involving all 13 Scottish Higher Education Institutions that are active in biotechnology research and…
-
Elevance picks URS for Natchez Biorefinery
.
I am still working on the Elevance-Versalis press releases, and hoping to score some additional information from the companies. In the meantime, let me post this earlier news from Elevance about its Natchez plant activities. Elevance Renewable Sciences has selected…
-
The quest for sustainable rubber
.
This has been in my draft for quite some time and I am glad to be able to post it after an interesting presentation that I heard from Patagonia and Yulex during the World Bio Markets USA conference last year…